Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Uterine Cervical Neoplasms × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Postoperative Analgesia 1 Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Cisplatin 3 spartalizumab 1 netupitant, palosentron drug combination 1 camrelizumab 1 Vaccines, Synthetic 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Drug Therapy 1 Dexamethasone 1 Control Groups 1 Carboplatin 1 Brachytherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡